Today in the Presumption of Regularity

Once again Federal Judge Judge James Boasberg has ruled against the Trump DoJ.

In this case, he has ruled that the Trump administration's demands for records from pro-trans organizations was retaliation for protected speech.

Basically, he's calling the government lying sacks of sh%$.

Last night, Chief Judge James E. Boasberg of the U.S. District Court for the District of Columbia granted preliminary injunctions in two parallel cases—Endocrine Society v. FTC and World Professional Association for Transgender Health v. FTC—enjoining the Federal Trade Commission from enforcing civil investigative demands against the two leading medical organizations on transgender health. The judge ruled in both cases that the FTC likely violated the organizations' First Amendment rights and engaged in unlawful retaliation against them for their protected speech supporting gender-affirming care. Boasberg further found that the Trump administration and the FTC had pursued the organizations based on "extensive evidence of animus" and "wafer-thin justifications" for their demands. For now, the private communications, internal deliberations, and member information of these two organizations are protected from the Trump administration's escalating campaign of government censorship and retaliation against the medical institutions that support transgender people.

"On this preliminary record, with extensive evidence of animus and wafer-thin justifications lacking evidentiary support, [the Court] finds that WPATH is likely to demonstrate a causal link between its protected speech and the FTC's issuance of the CID,” said the judge in the WPATH ruling. In the parallel Endocrine Society ruling issued the same day, the judge went likewise found similar violations: "The Court finds the same systemic targeting of proponents of medical treatment for gender incongruence at work here. The Society is the latest casualty in some Executive Branch agencies' bid to investigate hospitals, medical providers, and charitable organizations that support transgender health. The CID's focus on academic and medical speech, combined with the FTC's paucity of logic or evidence pointing to a genuine investigation, confirms the conclusion that the CID was likely issued for a retaliatory purpose."

The cases center on Civil Investigative Demands—administrative subpoenas the FTC issued to both organizations in January 2026, demanding sweeping and unprecedented access to their internal operations. The FTC ordered the organizations to turn over decades of internal communications about their clinical guidelines on gender dysphoria, every educational and advocacy material, every financial record, and the names of every member who had ever helped develop claims about gender-affirming care—potentially thousands of people. The CID to WPATH alarmingly reached back to 1979, the year WPATH was founded. The CIDs are part of a sprawling Trump administration campaign to suppress speech about transgender people and crush the institutions that provide it: the Kennedy Declaration, which drove more than 40 hospital systems to shutter their trans youth programs before a federal judge vacated it as unlawful last month; CMS proposed rules that would bar Medicare and Medicaid-receiving hospitals from providing such care entirely; and DOJ subpoenas to hospitals across the country, which federal judges have repeatedly quashed as "smokescreens" for retaliation. The FTC's CIDs were the latest weapon in that campaign.

We really need Nuremberg style tribunals when this is all done.